The Use of SmartPhone App (Kandoo) to Enhance Efficacy of Brief Behavioral Activation in Reducing Mood Disorder Symptoms
Kandoo
1 other identifier
interventional
200
1 country
1
Brief Summary
The current project is a pilot study that seeks to compare the efficacy of Brief Behavioral Activation's treatment-as-usual that uses paper and pencil tools to Kandoo, a digital, gamified version of activity scheduling and self-monitoring, in a diverse sample of youth presenting with clinically significant symptoms of depression. We will compare the level of pre- and post-treatment depressive symptoms in participants, who will participate in an 8-week brief behavioral activation treatment protocol augmented with Kandoo to the pre- and post- treatment depressive symptoms in the control participants, who will participate in 8-week, treatment as usual, brief behavioral activation treatment protocol. To explore treatment response for the clinically significant symptoms, we will obtain pre- and post-treatment measures of depression, global functioning, and patient goals. During the standard clinical intake, additional information will be obtained, including detailed demographics, medical history, mental health status, and social skills. Beyond determining the overall effectiveness of BBA augmented with Kandoo, the sample diversity and availability of clinical behavioral observations of the participants will permit the development of explanatory models of predictive factors for BBA with Kandoo intervention outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 10, 2025
CompletedFirst Posted
Study publicly available on registry
February 13, 2025
CompletedStudy Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
ExpectedFebruary 13, 2025
February 1, 2025
5 months
February 10, 2025
February 10, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Depressive Symptoms and Global Functioning
We will compare the pre- and post-treatment depressive symptoms and global functioning of participants, who completed BBA with Kandoo.
8 weeks
Secondary Outcomes (1)
Improvement Factors
8 weeks
Study Arms (2)
Brief Behavioral Activation with Kandoo
EXPERIMENTALParticipants will use Kandoo to track their activities while receiving Brief Behavioral Activation treatment.
Brief Behavioral Activation with traditional paper pencil tracking
NO INTERVENTIONParticipants will use paper and pencil worksheets to track their activities while receiving Brief Behavioral Activation treatment.
Interventions
Kandoo is an app that allows patients to track their activities in an engaging and gamified platform.
Eligibility Criteria
You may qualify if:
- Age: 13.0 to 25:11 years old
- Sex: male and female
- Currently enrolled as a patient in the CMI clinic or Fort Health Virtual Outpatient Mental Health Clinic
- Current clinical presentation must include symptoms of mild-to-moderate depression, two of which must be depressed/irritable mood most of the day and markedly diminished interest or pleasure in all, or almost all, activities most of the day, nearly every day
- Access to a smart device
- Internet connectivity
- Approval by parents and clinician for participants 13-17.11; approval by clinician for participants 18+
You may not qualify if:
- eating disorder
- manic episode (any current or history)
- psychotic episode or psychotic disorder
- active suicidality
- homicidal
- Any neurologic impairment that limits the ability to use a touch screen.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Child Mind Institutelead
- Fort Healthcollaborator
Study Sites (1)
Child Mind Institute
New York, New York, 10022, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Milham, MD, PhD
Child Mind Institute
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2025
First Posted
February 13, 2025
Study Start
March 1, 2025
Primary Completion
August 1, 2025
Study Completion (Estimated)
August 1, 2026
Last Updated
February 13, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share